KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to -$10.6 million.

  • Petmed Express' Consolidated Net Income fell 132223.72% to -$10.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$64.9 million, marking a year-over-year decrease of 2327321.43%. This contributed to the annual value of -$6.3 million for FY2025, which is 1576.9% up from last year.
  • Per Petmed Express' latest filing, its Consolidated Net Income stood at -$10.6 million for Q4 2025, which was down 132223.72% from -$8.5 million recorded in Q3 2025.
  • In the past 5 years, Petmed Express' Consolidated Net Income ranged from a high of $6.5 million in Q3 2021 and a low of -$34.2 million during Q2 2025
  • Its 5-year average for Consolidated Net Income is -$2.2 million, with a median of $66500.0 in 2021.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first soared by 202368.42% in 2022, then crashed by 1056842.11% in 2023.
  • Petmed Express' Consolidated Net Income (Quarter) stood at $4.4 million in 2021, then plummeted by 100.43% to -$19000.0 in 2022, then tumbled by 10568.42% to -$2.0 million in 2023, then skyrocketed by 63.39% to -$742000.0 in 2024, then tumbled by 1322.24% to -$10.6 million in 2025.
  • Its last three reported values are -$10.6 million in Q4 2025, -$8.5 million for Q3 2025, and -$34.2 million during Q2 2025.